Amgen Inc. boosted first-quarter profit by 51 percent, thanks to surging sales of its top prescription drugs and ongoing cost cuts designed to free up cash to mount an unprecedented spurt of new...
Over-the-counter medicines maker Perrigo is turning down a buyout offer from generic drugmaker Mylan that valued the company at $205 per share, or almost $29 billion, because it's too low.
Shares of some top biotechnology companies are mixed at 1 p.m.: Amgen Inc. rose $1.98 or 1.2 percent, to $167.95.
Pfizer said Tuesday that an experimental blood cancer drug met one of its two goals in a late-stage trial, as patients who were treated with the drug were more likely to have a complete remission.
Blue Bell Creameries is pulling all of its products off the shelves after samples of its ice cream tested positive for a potentially deadly bacteria — listeria.
The U.S. Dept. of Veterans Affairs was hit with a federal lawsuit on behalf of seven veterans who allege they have waited years for records needed to file for disability benefits.
Teva has offered to buy Mylan in a cash-and-stock deal valued at about $40.1 billion.
Texas-based Blue Bell Creameries issued a voluntary recall Monday night for all of its products on the market after two samples of chocolate chip cookie dough ice cream tested positive for...
Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter International Inc. rose $.45 or .6 percent, to $70.36.